Drs R. Ysermans, M.D.
Recent publications
-
Busch, M. H., Ysermans, R., Aendekerk, J., Timmermans, S. A., Potjewijd, J., Damoiseaux, J., Spronk, H. M. H., Ten Cate, H., Reutelingsperger, C., Nagy, M., & van Paassen, P. (2024). The intrinsic coagulation pathway plays a dominant role in driving hypercoagulability in ANCA-Associated Vasculitis. Blood advances, 8(5), 1295-1304. https://doi.org/10.1182/bloodadvances.2023011937More information about this publication
-
Verhoeven, D., Grinwis, L., Marsman, C., Jansen, M. H., Van Leeuwen, E. M. M., Kuijpers, T. W., Ruiter, A., van der Weele, L., Kielbassa, K., Coppola, M., Desai, J., van der Burg, M., Vletter, E., Braham, M., Busch, M., Bonasia, C., Raveling, E., Huizinga, R., Verstegen, N., ... T2B Consortium (2023). B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses. Life Science Alliance, 6(9), Article e202302214. https://doi.org/10.26508/lsa.202302214More information about this publication
-
Aendekerk, J. P., Ysermans, R., Busch, M. H., Theunissen, R. O. M. F. I. H., Bijnens, N., Potjewijd, J., Damoiseaux, J. G. M. C., Reutelingsperger, C. P., & van Paassen, P. (2023). Assessment of longitudinal serum neutrophil extracellular trap-inducing activity in anti-neutrophil cytoplasmic antibody-associated vasculitis and glomerulonephritis in a prospective cohort using a novel bio-impedance technique. Kidney International, 104(1), 151-162. https://doi.org/10.1016/j.kint.2023.03.029More information about this publication
-
Busch, M. H., Timmermans, S. A. M. E. G., Van Kuijk, S. M. J., Aendekerk, J. P., Ysermans, R., Van Doorn, D. P. C., Potjewijd, J., Van de Poll, M. C. G., Van der Horst, I. C. C., Damoiseaux, J. G. M. C., Spronk, H. M. H., Cate, H. T., Reutelingsperger, C. P., Nagy, M., & Van Paassen, P. (2023). Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19. Haematologica-the Hematology Journal, 108(5), 1417-1422. https://doi.org/10.3324/haematol.2022.281693More information about this publication
-
Ysermans, R., Busch, M. H., Aendekerk, J. P., Damoiseaux, J. G. M. C., & van Paassen, P. (2023). Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study. Journal of Translational Autoimmunity, 6(1), Article 100178. https://doi.org/10.1016/j.jtauto.2022.100178More information about this publication
-
Busch, M. H., Timmermans, S. A. M. E. G., Aendekerk, J. P., Ysermans, R., Amiral, J., Damoiseaux, J. G. M. C., Reutelingsperger, C. P., & Paassen, P. V. (2022). Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19. Journal of Clinical Medicine, 11(24), Article 7486. https://doi.org/10.3390/jcm11247486More information about this publication
-
Tobal, R., Potjewijd, J., van Empel, V. P. M., Ysermans, R., Schurgers, L. J., Reutelingsperger, C. P., Damoiseaux, J. G. M. C., & van Paassen, P. (2021). Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity. Frontiers in medicine, 8, Article 806899. https://doi.org/10.3389/fmed.2021.806899More information about this publication
-
Busch, M. H., Timmermans, S. A. M. E. G., Nagy, M., Visser, M., Huckriede, J., Aendekerk, J. P., de Vries, F., Potjewijd, J., Jallah, B., Ysermans, R., Oude Lashof, A. M. L., Breedveld, P. H., van de Poll, M. C. G., van de Horst, I. C. C., van Bussel, B. C. T., Theunissen, R. O. M. F. I. H., Spronk, H. M. H., Damoiseaux, J. G. M. C., ten Cate, H., ... van Paassen, P. (2020). Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19. Circulation, 142(18), 1787-1790. https://doi.org/10.1161/CIRCULATIONAHA.120.050656More information about this publication